Literature DB >> 23370971

Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia.

L Huang1, Y Y Zhang, L Y Sun.   

Abstract

The aim of this study was to systematically evaluate the predictive value of time to positivity (TTP) in candidemia. All first episodes of candidemic patients admitted to our hospital between January 2008 and July 2012 were recorded retrospectively. We analyzed the relationship between TTP, identification of Candida species, antifungal agent susceptibility, and patients' clinical characteristics (30-day mortality, underlying diseases, and associated risk factors). TTP of simulated blood culture with equal inoculum amounts of different Candida species was determined. We included 87 patients during the study period, with a mean TTP of 43.47 ± 19.51 h. TTP of C. glabrata was significantly longer (p < 0.001) and TTP of C. tropicalis was significantly shorter (p < 0.001) than that of other Candida species. Receiver operating characteristic (ROC) curve analysis showed that TTP can predict C. glabrata (with the cut-off value of >45.17 h) and C. tropicalis (with the cut-off value of ≤33.17 h) in candidemia with good sensitivity and specificity. No statistically significant relationship was found between TTP, antifungal agent susceptibility, and patients' clinical characteristics (p > 0.05). TTP was not a risk factor associated with mortality (p > 0.05). The TTP result in simulated blood culture was in accordance with that of the included patients. TTP has been demonstrated to be helpful to differentiate C. glabrata and C. tropicalis from other Candida species in candidemia, and it is not associated with antifungal agent susceptibility and patients' clinical characteristics. TTP cannot predict pathogen concentration in the blood of candidemic patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370971     DOI: 10.1007/s10096-013-1826-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  Time to blood culture positivity as a predictor of methicillin resistance in Staphylococcus aureus bacteremia.

Authors:  Chih-Cheng Lai; Cheng-Yi Wang; Wei-Lun Liu; Ching-Cheng Hou; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  J Infect       Date:  2010-11-23       Impact factor: 6.072

2.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

Authors:  Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden
Journal:  Clin Infect Dis       Date:  2006-05-16       Impact factor: 9.079

3.  Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia.

Authors:  R Álvarez; L Viñas-Castillo; J A Lepe-Jiménez; E García-Cabrera; J M Cisneros-Herreros
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

Review 4.  Invasive candidiasis: an overview from Taiwan.

Authors:  Sheng-Yuan Ruan; Po-Ren Hsueh
Journal:  J Formos Med Assoc       Date:  2009-06       Impact factor: 3.282

5.  Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol.

Authors:  Michael Gherna; William G Merz
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

6.  Resolution of discrepant results for Candida species identification by using DNA probes.

Authors:  Catherine Coignard; Steven F Hurst; Lynette E Benjamin; Mary E Brandt; David W Warnock; Christine J Morrison
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Time to blood culture positivity as a marker for catheter-related candidemia.

Authors:  Ronen Ben-Ami; Miriam Weinberger; Ruth Orni-Wasserlauff; David Schwartz; Avraham Itzhaki; Tzipora Lazarovitch; Edna Bash; Yuval Aharoni; Irina Moroz; Michael Giladi
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

8.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

Authors:  Olivier Leroy; Jean-Pierre Gangneux; Philippe Montravers; Jean-Paul Mira; François Gouin; Jean-Pierre Sollet; Jean Carlet; Jacques Reynes; Michel Rosenheim; Bernard Regnier; Olivier Lortholary
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

9.  Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.

Authors:  Shiang Ning Leaw; Hsien Chang Chang; Hsiao Fang Sun; Richard Barton; Jean-Philippe Bouchara; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia.

Authors:  Richard F Louie; Zuping Tang; Timothy E Albertson; Stuart Cohen; Nam K Tran; Gerald J Kost
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

View more
  8 in total

1.  Controlled Evaluation of the New BacT/Alert Virtuo Blood Culture System for Detection and Time to Detection of Bacteria and Yeasts.

Authors:  Osman Altun; Mohammed Almuhayawi; Petra Lüthje; Rubina Taha; Måns Ullberg; Volkan Özenci
Journal:  J Clin Microbiol       Date:  2016-02-03       Impact factor: 5.948

2.  Epidemiology and reporting of candidaemia in Belgium: a multi-centre study.

Authors:  C Trouvé; S Blot; M-P Hayette; S Jonckheere; S Patteet; H Rodriguez-Villalobos; F Symoens; E Van Wijngaerden; K Lagrou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-17       Impact factor: 3.267

3.  Time to positivity and detection of growth in anaerobic blood culture vials predict the presence of Candida glabrata in candidemia: a two-center European cohort study.

Authors:  Nazaret Cobos-Trigueros; Achim J Kaasch; Alex Soriano; Jorge-Luis Torres; Andrea Vergara; Laura Morata; Yuliya Zboromyrska; Cristina De La Calle; Izaskun Alejo; Cristina Hernández; Celia Cardozo; Franscesc Marco; Ana Del Río; Manel Almela; Josep Mensa; José Antonio Martínez
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

4.  Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.

Authors:  S Bailly; C Garnaud; M Cornet; P Pavese; R Hamidfar-Roy; L Foroni; S Boisset; J-F Timsit; D Maubon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-02       Impact factor: 3.267

5.  Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial.

Authors:  M Hong Nguyen; Peter G Pappas; Eleftherios Mylonakis; Ioannis M Zacharioudakis; Cornelius J Clancy
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

6.  Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods.

Authors:  Marc Vasse; Eric Farfour; Gauthier Péan de Ponfilly; Julie Lourtet-Hascoet; Huong Porcheret; Emmanuelle Cambau; Alban Le Monnier; Hervé Jacquier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-23       Impact factor: 3.267

7.  Time to Positivity Facilitates an Early Differential Diagnosis of Candida tropicalis from Other Candida species.

Authors:  Xianggui Yang; Mingquan Liu; Xuejing Yu; Zhenguo Wang; Ying Xu
Journal:  Infect Drug Resist       Date:  2022-10-10       Impact factor: 4.177

Review 8.  T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications.

Authors:  Ioannis M Zacharioudakis; Fainareti N Zervou; Eleftherios Mylonakis
Journal:  J Fungi (Basel)       Date:  2018-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.